Cell-type dependent selectivity of CCK2R signaling (WP3679)

Homo sapiens

This pathway is based on Figure 7 of "Cell-Type Specific CCK2 Receptor Signaling Underlies the Cholecystokinin-Mediated Selective Excitation of Hippocampal Parvalbumin-Positive Fast-Spiking Basket Cells."(See Bibliography).The neuropeptide cholecystokinin (CCK) acts through its receptor CCK2R to achieve largely different functions in different types of cells. CCK, CCK2R, and CB1R have all been known to have substantial effects on anxiety and other mood disorders, and the PV+ interneurons have also been shown to be involved i na variety of cognitive functions. However, In PV+ basket cells and CCK+ basket cells, the CCK2 receptor uses different pathways to exert different effects on the two types of basket cells. For CCK+ basket cells, CCK2 receptors in neighboring pyramidal cells act through the Gq pathway to form endocannabinoids, which, through the cannabinoid receptor type 1 on the CCK+ basket cell, inhibit the release of the neurotransmitter GABA. In contrast, for PV+ basket cells, CCK2 receptors act through the pertussin-toxin sensitive Gi pathway to regulate the intracellular Ca2+ through ryanodine receptors. This pathway ultimately leads to activation of a non-selective cationic conductance to depolarize the PV+ basket cells.

Authors

AAR&Co , Martina Summer-Kutmon , Anders Riutta , Kristina Hanspers , Denise Slenter , Egon Willighagen , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Disease Ontology

pertussis

Cell Type Ontology

pyramidal neuron basket cell

Pathway Ontology

signaling pathway

Participants

Label Type Compact URI Comment
2-APB Metabolite wikidata:Q4596857
DAG Metabolite chebi:18035
YM022 Metabolite pubchem.compound:122130
cyclic ADPR Metabolite pubchem.compound:123847
8-NH2-cADPR Metabolite pubchem.compound:3081323 artifically added antagonist of cyclic ADPR
Flufenamic acid Metabolite chebi:42638
GABA Metabolite chemspider:116 gamma-Aminobutyric acid
inhibitory neurotransmitter in mammalian CNS
NEM Metabolite chemspider:4209
Ca2+ Metabolite chebi:29108
Ryanodine Metabolite chemspider:16736002 artificially added inhibitor of ryanodine receptor
endocannabinoids Metabolite chebi:67197
U-73122 Metabolite wikidata:Q27089044
YM022 Metabolite pubchem.compound:122130
Ca2+ Metabolite chebi:29108
Ca2+ Metabolite chebi:29108
Ca2+ Metabolite chebi:29108
GABA Metabolite chemspider:116 gamma-Aminobutyric acid
inhibitory neurotransmitter in mammalian CNS
GABA Metabolite chemspider:116 gamma-Aminobutyric acid
inhibitory neurotransmitter in mammalian CNS
GABA Metabolite chemspider:116 gamma-Aminobutyric acid
inhibitory neurotransmitter in mammalian CNS
Ca2+ Metabolite chebi:29108
Ca2+ Metabolite chebi:29108
Na+ Metabolite chebi:29101
Na+ Metabolite chebi:29101
Ca2+ Metabolite chebi:29108
Ca2+ Metabolite chebi:29108
endocannabinoids Metabolite chebi:67197
IP3 receptor GeneProduct ensembl:ENSG00000150995
Gi/0 GeneProduct ensembl:ENSG00000127955
Gq GeneProduct ensembl:ENSG00000156052
CCK2R GeneProduct ensembl:ENSG00000110148 receptor
RYR1 GeneProduct ensembl:ENSG00000196218
TRPC1 GeneProduct ensembl:ENSG00000144935 likely forms complexes with TRPC4 and TRPC5
transient receptor potential ion channel
DAG lipase GeneProduct ensembl:ENSG00000134780
CCK GeneProduct ensembl:ENSG00000187094
PLCB1 GeneProduct ensembl:ENSG00000182621
CB1 GeneProduct ensembl:ENSG00000118432 Cannabinoid receptor 1
ADP-Ribose cyclase GeneProduct ensembl:ENSG00000004468
CCK GeneProduct ensembl:ENSG00000187094
CCK2R GeneProduct ensembl:ENSG00000110148 receptor
RYR2 GeneProduct ensembl:ENSG00000198626
RYR3 GeneProduct ensembl:ENSG00000198838
RYR1 GeneProduct ensembl:ENSG00000196218
RYR2 GeneProduct ensembl:ENSG00000198626
RYR3 GeneProduct ensembl:ENSG00000198838

References

  1. Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells. Lee SH, Soltesz I. J Physiol. 2011 Feb 15;589(Pt 4):891–902. PubMed Europe PMC Scholia
  2. Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells. Lee SY, Földy C, Szabadics J, Soltesz I. J Neurosci. 2011 Jul 27;31(30):10993–1002. PubMed Europe PMC Scholia